Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene

MLA

Fabrizio Barbetti, et al. Sulfonylurea Treatment Outweighs Insulin Therapy in Short-Term Metabolic Control of Patients with Permanent Neonatal Diabetes Mellitus Due to Activating Mutations of the KCNJ11 (KIR6.2) Gene. Jan. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e5b64f51ed4feefbefe869607e21337&authtype=sso&custid=ns315887.

APA

Fabrizio Barbetti, Stefano Tumini, Riccardo Bonfanti, D. Iafusco, Franco Meschi, Carla Bizzarri, Marco Cappa, F. Cerutti, Francesco Prisco, E. Ciacco, C. Torelli, Maurizio Vanelli, E. Faleschini, V. Cauvin, & G. Tonini. (2006). Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.

Chicago

Fabrizio Barbetti, Stefano Tumini, Riccardo Bonfanti, D. Iafusco, Franco Meschi, Carla Bizzarri, Marco Cappa, et al. 2006. “Sulfonylurea Treatment Outweighs Insulin Therapy in Short-Term Metabolic Control of Patients with Permanent Neonatal Diabetes Mellitus Due to Activating Mutations of the KCNJ11 (KIR6.2) Gene,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8e5b64f51ed4feefbefe869607e21337&authtype=sso&custid=ns315887.